Synthesis of Linear and Cyclic Hexapeptides with Ne-(1,2-Dihydro-1-hydroxy-2-oxopyrimidin-4-yl)-L-lysyl-b-alanyl as the Repeating Unit and Properties of Their Iron(III) Complexes
摘要:
Linear and cyclic hexapeptides including N-epsilon(1,2-dihydro-1hydroxy-2-oxopyrimidin-4-yl)-L-lysyl-beta-alanyl as the repeating unit have been synthesized. These hexapeptides formed 1:1 iron(III) complexes; lambda(max) 466 nm and epsilon 4700 for a linear hexapeptide (8), and lambdamax 458 nm and epsilon 4300 for a cyclic hexapeptide (9). The relative stability constants of 8- and 9-iron(III) complexes were estimated to be 26.1 and 28.0, respectively. A linear hexapeptide (8)iron(III) complex predominantly existed in Delta-configuration. From kinetic data on iron(III) removal from human transferrin, a linear hexapeptides (8) was found to efficiently remove three times as much iron(III) from transferrin as desferrioxamine B, only a chemotherapeutic agent for the iron overload disease.
Synthesis of Linear and Cyclic Hexapeptides with Ne-(1,2-Dihydro-1-hydroxy-2-oxopyrimidin-4-yl)-L-lysyl-b-alanyl as the Repeating Unit and Properties of Their Iron(III) Complexes
摘要:
Linear and cyclic hexapeptides including N-epsilon(1,2-dihydro-1hydroxy-2-oxopyrimidin-4-yl)-L-lysyl-beta-alanyl as the repeating unit have been synthesized. These hexapeptides formed 1:1 iron(III) complexes; lambda(max) 466 nm and epsilon 4700 for a linear hexapeptide (8), and lambdamax 458 nm and epsilon 4300 for a cyclic hexapeptide (9). The relative stability constants of 8- and 9-iron(III) complexes were estimated to be 26.1 and 28.0, respectively. A linear hexapeptide (8)iron(III) complex predominantly existed in Delta-configuration. From kinetic data on iron(III) removal from human transferrin, a linear hexapeptides (8) was found to efficiently remove three times as much iron(III) from transferrin as desferrioxamine B, only a chemotherapeutic agent for the iron overload disease.